🇺🇸 FDA
Pipeline program

Anti-CD5 CAR NK cells

PBC083

Phase 1 mab active

Quick answer

Anti-CD5 CAR NK cells for T-ALL/Lymphoma is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
T-ALL/Lymphoma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials